We are live on ! Find out more
HALO icon

Halozyme

166 hedge funds and large institutions have $2.11B invested in Halozyme in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 66 increasing their positions, 54 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

817% more call options, than puts

Call options by funds: $63.7M | Put options by funds: $6.95M

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

35% more capital invested

Capital invested by funds: $1.56B → $2.11B (+$548M)

22% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 54

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

1% less funds holding

Funds holding: 167166 (-1)

1.59% less ownership

Funds ownership: 87.22%85.64% (-1.6%)

Holders
166
Holders Change
-1
Holders Change %
-0.6%
% of All Funds
4.14%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
15
Increased
66
Reduced
54
Closed
13
Calls
$63.7M
Puts
$6.95M
Net Calls
+$56.7M
Net Calls Change
+$26.2M
Name Holding Trade Value Shares
Change
Change in
Stake
RCMNY
26
Rubric Capital Management (New York)
New York
$13.6M +$6.54M +483,000 +161%
Two Sigma Investments
27
Two Sigma Investments
New York
$13.6M +$5.29M +390,279 +100%
Millennium Management
28
Millennium Management
New York
$12.9M +$2.05M +151,178 +26%
Deutsche Bank
29
Deutsche Bank
Germany
$11M +$3.49M +257,917 +68%
Fisher Asset Management
30
Fisher Asset Management
Washington
$10.1M -$417K -30,800 -5%
Charles Schwab
31
Charles Schwab
California
$9.91M +$795K +58,707 +11%
KCM
32
Kennedy Capital Management
Missouri
$9.82M +$262K +19,329 +4%
Morgan Stanley
33
Morgan Stanley
New York
$9.74M +$410K +30,257 +6%
Macquarie Group
34
Macquarie Group
Australia
$8.69M
FLAM
35
First Light Asset Management
Minnesota
$7.74M +$396K +29,267 +7%
Goldman Sachs
36
Goldman Sachs
New York
$7.74M +$513K +37,885 +9%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$6.55M +$4.96M +366,302 +3,314%
FAM
38
Fred Alger Management
New York
$6.35M +$461K +34,000 +10%
O
39
OrbiMed
New York
$6.08M
Wells Fargo
40
Wells Fargo
California
$5.62M -$322K -23,780 -7%
SEI Investments
41
SEI Investments
Pennsylvania
$5.6M -$173K -12,763 -4%
TCIM
42
TIAA CREF Investment Management
New York
$5.47M +$265K +19,592 +7%
IBT
43
International Biotechnology Trust
United Kingdom
$4.91M +$1.06M +78,000 +38%
American Century Companies
44
American Century Companies
Missouri
$4.79M +$2.24M +165,663 +150%
CS
45
Credit Suisse
Switzerland
$4.78M +$392K +28,945 +12%
State of New Jersey Common Pension Fund D
46
State of New Jersey Common Pension Fund D
New Jersey
$4.43M +$1.02M +75,000 +42%
Adage Capital Partners
47
Adage Capital Partners
Massachusetts
$4.34M -$1.02M -75,000 -23%
CM
48
Castleark Management
Illinois
$4.05M +$3.15M +232,905 New
TA
49
Teachers Advisors
New York
$3.84M +$222K +16,408 +8%
GC
50
Guggenheim Capital
Illinois
$3.71M +$9.96K +735 +0.3%

HALO Hedge Fund Activity: Q3 2017 in Review

166 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2017, worth a combined $2.11B — up 35% from $1.56B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new HALO positions and 13 closed out — a net gain of 2 holders — while 66 added to existing stakes and 54 trimmed.

The largest buyer was BlackRock, adding an estimated $7.71M. The largest seller was Third Security, cutting an estimated $23.5M.

  • 166 institutional investors held Halozyme (HALO) as of Q3 2017, down from 167 in Q2 2017.
  • Funds reported $2.11B of Halozyme stock for Q3 2017, up 35% quarter-over-quarter.
  • 15 funds opened new Halozyme positions in Q3 2017 and 13 closed out, a net change of +2 holders.
  • The largest Halozyme buyer in Q3 2017 was BlackRock, an estimated $7.71M added.
  • The largest Halozyme seller in Q3 2017 was Third Security, an estimated $23.5M sold.

Based on aggregated 13F filings for Q3 2017.